Gordon Craig E, Balk Ethan M, Becker Bryan N, Crooks Peter A, Jaber Bertrand L, Johnson Cynda A, Michael Maureen A, Pereira Brian J G, Uhlig Katrin, Levin Adeera
Tufts Center for Guideline Development and Implementation, Tufts Medical Center, Boston, MA, USA.
Am J Kidney Dis. 2008 Nov;52(5):811-25. doi: 10.1053/j.ajkd.2008.08.005.
KDIGO (Kidney Disease: Improving Global Outcomes) is an international initiative with a key mission of developing clinical practice guidelines in the area of chronic kidney disease (CKD). KDIGO recently published evidence-based clinical practice guidelines for the prevention, diagnosis, evaluation, and treatment of hepatitis C virus infection in individuals with CKD. The process of adaptation of international guidelines is an important task that, although guided by general principles, needs to be individualized for each region and country. Therefore, the National Kidney Foundation-Kidney Disease Outcomes Quality Initiative (KDOQI) convened a multidisciplinary group to comment on the application and implementation of the KDIGO guidelines for patients with CKD in the United States. This commentary summarizes the process undertaken by this group in considering the guidelines in the context of health care delivery in the United States. Guideline statements are presented, followed by a succinct discussion and annotation of the rationale for the statements. Research recommendations that are of particular interest to the United States are then summarized to highlight future areas of inquiry that would enable updating of the guidelines.
KDIGO（改善全球肾脏病预后组织）是一项国际倡议，其关键使命是制定慢性肾脏病（CKD）领域的临床实践指南。KDIGO最近发布了关于CKD患者丙型肝炎病毒感染的预防、诊断、评估和治疗的循证临床实践指南。国际指南的改编过程是一项重要任务，尽管有一般原则的指导，但需要针对每个地区和国家进行个体化。因此，美国国家肾脏基金会-肾脏病预后质量倡议（KDOQI）召集了一个多学科小组，就KDIGO指南在美国CKD患者中的应用和实施发表意见。本述评总结了该小组在美国医疗保健服务背景下考虑这些指南所采取的过程。先列出指南声明，随后对声明的理由进行简要讨论和注释。接着总结了美国特别感兴趣的研究建议，以突出未来能够使指南更新的研究领域。
